A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments

about

Icotinib and whole-brain radiotherapy for the treatment in patients with brain metastases from EGFR-mutant nonsmall cell lung cancer: A retrospective study.The intracellular signalosome of PD-L1 in cancer cells

P2860

Q54116530-8F33C37A-3C01-432E-A20D-89774B9A78E5 Q57067759-D9E664EB-BFE2-4B11-ABE5-FFA5CDF1200C

P2860

A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments

Item

http://www.wikidata.org/entity/Q42370827

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

A study of PD-L1 expression in ...... o relevant targeted treatments

@en

A study of PD-L1 expression in ...... o relevant targeted treatments

@nl

type

Item

label

A study of PD-L1 expression in ...... o relevant targeted treatments

@en

A study of PD-L1 expression in ...... o relevant targeted treatments

@nl

prefLabel

A study of PD-L1 expression in ...... o relevant targeted treatments

@en

A study of PD-L1 expression in ...... o relevant targeted treatments

@nl

P1476

A study of PD-L1 expression in ...... o relevant targeted treatments

@en

P2093

Adam Stewart

http://www.w3.org/2001/XMLSchema#string

Alexandros Georgiou

http://www.w3.org/2001/XMLSchema#string

Jaishree Bhosle

http://www.w3.org/2001/XMLSchema#string

Johann de Bono

http://www.w3.org/2001/XMLSchema#string

Mary E R O'Brien

http://www.w3.org/2001/XMLSchema#string

Parames Thavasu

http://www.w3.org/2001/XMLSchema#string

Timothy A Yap

http://www.w3.org/2001/XMLSchema#string

Zai Ahmad

http://www.w3.org/2001/XMLSchema#string

P2860

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study.

First-line crizotinib versus chemotherapy in ALK-positive lung cancer.

Global cancer statistics, 2012

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Comprehensive molecular profiling of lung adenocarcinoma.

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

Targeting pathways downstream of KRAS in lung adenocarcinoma.

Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors.

Cell-signalling dynamics in time and space.

P304

e0186106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0186106

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Udai Banerji

Sanjay Popat

Anna Minchom

P577

2017-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28982179

http://www.w3.org/2001/XMLSchema#string

P932

5628934

http://www.w3.org/2001/XMLSchema#string

A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments

about

P2860

P2860

A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932